Stueland Katherine

CHIEF EXECUTIVE OFFICER, DirectorGeneDx Holdings Corp. (WGS) · full profile →Form 4 · filed Jun 11, 2026
Net Selling
Open-Market Buys
$0
Open-Market Sells
$196K
Net Open-Market Flow
-$196K
Transactions
3
2 non-derivative · 1 derivative

Non-Derivative Transactions (Table I)

DateActionSharesPriceValueOwned After
Jun 9, 2026Option exercise(M)7K$0100K
Jun 9, 2026Sell(S)4K$53.77$196K96K

Derivative Transactions (Table II)

DateActionSharesPriceValueOwned After
Jun 9, 2026Option exercise(M)7K$013K

Transaction Codes

M
Option exercise / conversion
S
Open-market sale

Data Source & Provenance

Parsed from a single SEC EDGAR Form 4 filing (accession 0001689575-26-000026) within minutes of acceptance. Every field above traces to the original document. Verify it directly: